ArticleOncogenesis2021

Disruptor of telomeric silencing 1-like promotes ovarian cancer tumor growth by stimulating pro-tumorigenic metabolic pathways and blocking apoptosis.

Suresh Chava et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.